Skip to main content
Skip to search
Skip to main menu
Skip to page specific menu
Skip to footer area
Site Menu
Search
Close Search
Search the Schiffer Lab site
Search
A-Z
|
Search All UMass Chan Sites
Search
Close Search
Search the Schiffer Lab site
Search
A-Z
|
Search All UMass Chan Sites
Schiffer Lab
Biochemistry and Molecular Biotechnology
Research
Research
Overview: Drug Resistance
Molecular Basis for Resistance
Substrate Envelope
Inhibitor Design
Integrated Strategies to Elucidate Molecular Recognition
Introducing Sequence Diversity: APOBEC3s
Scientific Leadership
Scientific Leadership
About Celia Schiffer
Institute for Drug Resistance
Structure Based Drug Design Core
Cryo EM Core Facility
Publications
Publications
Dissertations
Journal Publications
People
People
Current Members
Alumni
Collaborations
In the News
Additional Resources
Page Menu
x
Publications
Dissertations
Journal Publications
Publications
Dissertations
Journal Publications
Publications
Total:
10
results
Systematic Analyses of the Resistance Potential of Drugs Targeting SARS-CoV-2 Main Protease
June 30, 2023
Systematic Analyses of the Resistance Potential of Drugs Targeting SARS-CoV-2 Main Protease Flynn, Julia M; Huang, Qiu Yu J; Zvornicanin, Sarah N; Schneider-Nachum, Gila; Shaqra, Ala M; Yilmaz, Nese K...
FruitFire: a luciferase based on a fruit fly metabolic enzyme [preprint]
June 30, 2023
FruitFire: a luciferase based on a fruit fly metabolic enzyme [preprint] Adams, Spencer T; Zephyr, Jacqueto; Bohn, Markus F; Schiffer, Celia A; Miller, Stephen C Firefly luciferase is homologous to fa...
HIV-1 protease inhibitors with a P1 phosphonate modification maintain potency against drug-resistant variants by increased interactions with flap residues
May 18, 2023
HIV-1 protease inhibitors with a P1 phosphonate modification maintain potency against drug-resistant variants by increased interactions with flap residues Lockbaum, Gordon J; Rusere, Linah N; Henes, M...
Crystal Structures of Inhibitor-Bound Main Protease from Delta- and Gamma-Coronaviruses
March 18, 2023
Crystal Structures of Inhibitor-Bound Main Protease from Delta- and Gamma-Coronaviruses Zvornicanin, Sarah N; Shaqra, Ala M; Huang, Qiuyu J; Ornelas, Elizabeth; Moghe, Mallika; Knapp, Mark; Moquin, St...
Selection of HIV-1 for resistance to fifth-generation protease inhibitors reveals two independent pathways to high-level resistance
March 15, 2023
Selection of HIV-1 for resistance to fifth-generation protease inhibitors reveals two independent pathways to high-level resistance Spielvogel, Ean; Lee, Sook-Kyung; Zhou, Shuntai; Lockbaum, Gordon J;...
Non-canonical pattern recognition of a pathogen-derived metabolite by a nuclear hormone receptor identifies virulent bacteria in C. elegans
February 15, 2023
Non-canonical pattern recognition of a pathogen-derived metabolite by a nuclear hormone receptor identifies virulent bacteria in C. elegans Peterson, Nicholas D; Tse, Samantha Y; Huang, Qiuyu Judy; Wa...
Allosteric quinoxaline-based inhibitors of the flavivirus NS2B/NS3 protease
November 19, 2022
Allosteric quinoxaline-based inhibitors of the flavivirus NS2B/NS3 protease Zephyr, Jacqueto; Rao, Desaboini Nageswara; Johnson, Colby; Shaqra, Ala M; Nalivaika, Ellen A; Jordan, Aria; Kurt Yilmaz, Ne...
Structure of the catalytically active APOBEC3G bound to a DNA oligonucleotide inhibitor reveals tetrahedral geometry of the transition state
November 19, 2022
Structure of the catalytically active APOBEC3G bound to a DNA oligonucleotide inhibitor reveals tetrahedral geometry of the transition state Maiti, Atanu; Hedger, Adam K; Myint, Wazo; Balachandran, Va...
Dual Inhibitors of Main Protease (M) and Cathepsin L as Potent Antivirals against SARS-CoV2
November 10, 2022
Dual Inhibitors of Main Protease (M) and Cathepsin L as Potent Antivirals against SARS-CoV2 Mondal, Santanu; Chen, Yongzhi; Lockbaum, Gordon J; Sen, Sudeshna; Chaudhuri, Sauradip; Reyes, Archie C; Lee...
Mucosal nanobody IgA as inhalable and affordable prophylactic and therapeutic treatment against SARS-CoV-2 and emerging variants
September 12, 2022
Mucosal nanobody IgA as inhalable and affordable prophylactic and therapeutic treatment against SARS-CoV-2 and emerging variants Li, Qi; Humphries, Fiachra; Girardin, Roxie C; Wallace, Aaron; Ejemel, ...
Back To Top ▲
Close
Research
Research
Overview: Drug Resistance
Molecular Basis for Resistance
Substrate Envelope
Inhibitor Design
Integrated Strategies to Elucidate Molecular Recognition
Introducing Sequence Diversity: APOBEC3s
Scientific Leadership
Scientific Leadership
About Celia Schiffer
Institute for Drug Resistance
Structure Based Drug Design Core
Cryo EM Core Facility
Publications
Publications
Dissertations
Journal Publications
People
People
Current Members
Alumni
Collaborations
In the News
Additional Resources